Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 1736.44
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 30-Oct-2026
NAV [Rs.]
: 27.8861
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 7.08 | 2.58 | 2.94 | 16.83 | 22.08 | 22.91 | 14.89 | 13.21 |
| Category Avg | 1.73 | -1.64 | -6.03 | -3.59 | -3.23 | 12.61 | 9.1 | 6.55 |
| Category Best | 7.37 | 18.07 | 7.61 | 17.47 | 39.68 | 39.87 | 24.54 | 105.69 |
| Category Worst | -6.07 | -17.51 | -22.26 | -24.4 | -33.93 | -3.85 | 0.66 | -30.35 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 19.50 | 1864349 | 338.67 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 11.97 | 223780 | 207.92 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 7.82 | 685768 | 135.78 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 7.68 | 990875 | 133.37 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 7.62 | 1073802 | 132.39 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 7.16 | 259104 | 124.36 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 5.00 | 427699 | 86.83 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.69 | 486612 | 81.36 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.56 | 265105 | 61.89 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.16 | 106169 | 54.82 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.92 | 436319 | 50.70 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.88 | 199532 | 49.95 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.71 | 244621 | 47.13 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 2.62 | 1227131 | 45.44 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.34 | 140334 | 40.68 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.14 | 243541 | 37.12 |
| Equity | Wockhardt | Pharmaceuticals & Biotechnology | 1.77 | 145451 | 30.78 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.67 | 80268 | 29.06 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.43 | 9176 | 24.88 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.30 | 1093760 | 22.58 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
8,03,520.11
Trustee/s:
NA
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
NA
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
